MedTrace Logo

Development of a New Tool for Dyspnea Measurement in Chronic Respiratory Diseases

NCT02229994 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 199

Last updated 2025-11-20

No results posted yet for this study

Summary

The purpose of this study is the psychometric validation of a self-administered dyspnea questionnaire, usable in clinical practice in order to assess dyspnea and its impact on patients with chronic respiratory diseases.

Conditions

  • COPD (With - Without Rehabilitation)
  • Diffuse Interstitial Lung Diseases
  • Pulmonary Arterial Hypertension Primary or Secondary (Post Embolic .....)
  • Cystic Fibrosis of the Adult

Interventions

OTHER

Cross sectional psychometric evaluation of a self-administered dyspnea questionnaire.

Evaluation will be performed on a group of 200 patients deriving from 4 samples. * From these 200 patients, a sub-sample will be evaluated at 7 days (DYSLIM questionnaire only) for reproducibility (n = 50 patients: 10 patients with diffuse interstitial lung disease, 10 patients with cystic fibrosis, 10 patients with arterial pulmonary hypertension, 20 patients with COPD). * From these 200 patients, a sub-sample (COPD, n = 60) will be recruited among patients undergoing pulmonary rehabilitation at the beginning of the 6 months separating follow up visit and the initial assessment.

Sponsors & Collaborators

  • Pr Joel COSTE, Hôpital Hôtel Dieu - Unité de Bio Statistiques et Epidémiologiques, Paris

    collaborator UNKNOWN

  • URC-CIC Paris Descartes Necker Cochin

    collaborator OTHER

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Thierry Perez, MD · CHRU de Lille / Hôpital Calmette - France

  • Nicolas ROCHE, MD, PhD · APHP- Hopital Cochin

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-16
Primary Completion
2014-03-27
Completion
2015-12-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02229994 on ClinicalTrials.gov